Reviva Pharmaceuticals Holdings Stock Analysis

Reviva Stock Analysis Notes

About 14.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.08. Reviva Pharmaceuticals had not issued any dividends in recent years. Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. Reviva Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To find out more about Reviva Pharmaceuticals Holdings contact Laxminarayan Bhat at 408 501 8881 or learn more at https://www.revivapharma.com.

Reviva Pharmaceuticals Investment Alerts

Reviva Pharmaceuticals Upcoming and Recent Events

Reviva Largest EPS Surprises

View All Earnings Estimates

Reviva Stock Institutional Investors

Note, although Reviva Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Reviva Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.04 M.

Reviva Profitablity

Management Efficiency

Reviva Pharmaceuticals has return on total asset (ROA) of (3.2778) % which means that it has lost $3.2778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.9506) %, meaning that it created substantial loss on money invested by shareholders. Reviva Pharmaceuticals' management efficiency ratios could be used to measure how well Reviva Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The Reviva Pharmaceuticals' current Return On Tangible Assets is estimated to increase to about (1.8 M). The Reviva Pharmaceuticals' current Return On Capital Employed is estimated to increase to about (6.6 M). As of now, Reviva Pharmaceuticals' Net Tangible Assets are increasing as compared to previous years. The Reviva Pharmaceuticals' current Other Assets is estimated to increase to about 467.6 K, while Total Current Assets are projected to decrease to under 15.2 M.

Technical Drivers

As of the 29th of March, Reviva Pharmaceuticals holds the Variance of 38.87, coefficient of variation of (2,122), and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Reviva Pharmaceuticals, as well as the relationship between them.

Reviva Pharmaceuticals Price Movement Analysis

Reviva Pharmaceuticals Insider Trading Activities

Reviva Pharmaceuticals Outstanding Bonds

Reviva Pharmaceuticals Predictive Daily Indicators

Reviva Pharmaceuticals Forecast Models

Reviva Pharmaceuticals' time-series forecasting models are one of many Reviva Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Reviva Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Reviva Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Reviva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Reviva Pharmaceuticals. By using and applying Reviva Stock analysis, traders can create a robust methodology for identifying Reviva entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Reviva analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Reviva analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Reviva Pharmaceuticals Holdings stock analysis indicators help investors evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By understating and applying Reviva Pharmaceuticals stock analysis, traders can identify Reviva Pharmaceuticals position entry and exit signals to maximize returns.

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.